Nitric oxide pathway — Drug Target

All drugs that target Nitric oxide pathway — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nitric oxide-releasing topical agent

Phase 3 pipeline (1)

• SB206 12% · Novan, Inc. · Nitric oxide-releasing topical agent · Dermatology
  SB206 is a nitric oxide-releasing topical agent that delivers nitric oxide to skin lesions to promote healing and reduce bacterial burden.